HEADER CHAPERONE 27-AUG-04 1WP0 TITLE HUMAN SCO1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SCO1 PROTEIN HOMOLOG; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: IMS FRAGMENT; COMPND 5 SYNONYM: HSCO1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21-RIL; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24D KEYWDS CU-BINDING PROTEIN, MITOCHONDRIAL ASSEMBLY FACTOR, REDOX, KEYWDS 2 CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.WILLIAMS,C.SUE,G.S.BANTING,H.YANG,D.M.GLERUM, AUTHOR 2 W.A.HENDRICKSON,E.A.SCHON REVDAT 3 24-FEB-09 1WP0 1 VERSN REVDAT 2 19-APR-05 1WP0 1 JRNL REVDAT 1 18-JAN-05 1WP0 0 JRNL AUTH J.C.WILLIAMS,C.SUE,G.S.BANTING,H.YANG,D.M.GLERUM, JRNL AUTH 2 W.A.HENDRICKSON,E.A.SCHON JRNL TITL CRYSTAL STRUCTURE OF HUMAN SCO1: IMPLICATIONS FOR JRNL TITL 2 REDOX SIGNALING BY A MITOCHONDRIAL CYTOCHROME C JRNL TITL 3 OXIDASE "ASSEMBLY" PROTEIN JRNL REF J.BIOL.CHEM. V. 280 15202 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15659396 JRNL DOI 10.1074/JBC.M410705200 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 28470 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1463 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3883 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WP0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-AUG-04. REMARK 100 THE RCSB ID CODE IS RCSB023833. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97887, 0.97928, 0.96864, REMARK 200 0.98713 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30575 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, 200MM NASCN, 5% XYLITOL, REMARK 280 PH 7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.10500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.58400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.57700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.58400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.10500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.57700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 137 REMARK 465 ARG A 298 REMARK 465 LYS A 299 REMARK 465 LYS A 300 REMARK 465 SER A 301 REMARK 465 ARG B 298 REMARK 465 LYS B 299 REMARK 465 LYS B 300 REMARK 465 SER B 301 REMARK 465 ARG C 298 REMARK 465 LYS C 299 REMARK 465 LYS C 300 REMARK 465 SER C 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 194 -173.29 -59.99 REMARK 500 SER A 221 139.62 171.37 REMARK 500 ASP A 251 -161.13 -72.56 REMARK 500 HIS B 145 1.94 -67.45 REMARK 500 ASP B 171 -67.41 -108.42 REMARK 500 PRO B 194 -175.15 -63.91 REMARK 500 ASP B 208 89.39 -61.62 REMARK 500 SER B 221 152.02 179.12 REMARK 500 GLU B 252 64.72 -68.83 REMARK 500 ASP B 253 8.58 -178.30 REMARK 500 TYR B 256 148.19 -178.29 REMARK 500 PRO B 296 5.41 -63.97 REMARK 500 ASP C 171 -50.24 -126.37 REMARK 500 PRO C 194 -168.51 -57.16 REMARK 500 SER C 221 150.02 179.13 REMARK 500 ASP C 253 14.37 86.57 REMARK 500 GLU C 254 7.67 51.34 REMARK 500 LEU C 274 -33.65 -141.54 REMARK 500 PRO C 296 -82.60 -54.01 REMARK 500 REMARK 500 REMARK: NULL DBREF 1WP0 A 138 301 UNP O75880 SCO1_HUMAN 138 301 DBREF 1WP0 B 138 301 UNP O75880 SCO1_HUMAN 138 301 DBREF 1WP0 C 138 301 UNP O75880 SCO1_HUMAN 138 301 SEQADV 1WP0 MSE A 137 UNP O75880 INITIATING METHIONINE SEQADV 1WP0 MSE A 180 UNP O75880 MET 180 MODIFIED RESIDUE SEQADV 1WP0 MSE A 264 UNP O75880 MET 264 MODIFIED RESIDUE SEQADV 1WP0 MSE A 294 UNP O75880 MET 294 MODIFIED RESIDUE SEQADV 1WP0 MSE B 137 UNP O75880 INITIATING METHIONINE SEQADV 1WP0 MSE B 180 UNP O75880 MET 180 MODIFIED RESIDUE SEQADV 1WP0 MSE B 264 UNP O75880 MET 264 MODIFIED RESIDUE SEQADV 1WP0 MSE B 294 UNP O75880 MET 294 MODIFIED RESIDUE SEQADV 1WP0 MSE C 137 UNP O75880 INITIATING METHIONINE SEQADV 1WP0 MSE C 180 UNP O75880 MET 180 MODIFIED RESIDUE SEQADV 1WP0 MSE C 264 UNP O75880 MET 264 MODIFIED RESIDUE SEQADV 1WP0 MSE C 294 UNP O75880 MET 294 MODIFIED RESIDUE SEQRES 1 A 165 MSE GLY PRO PHE SER LEU THR THR HIS THR GLY GLU ARG SEQRES 2 A 165 LYS THR ASP LYS ASP TYR LEU GLY GLN TRP LEU LEU ILE SEQRES 3 A 165 TYR PHE GLY PHE THR HIS CYS PRO ASP VAL CYS PRO GLU SEQRES 4 A 165 GLU LEU GLU LYS MSE ILE GLN VAL VAL ASP GLU ILE ASP SEQRES 5 A 165 SER ILE THR THR LEU PRO ASP LEU THR PRO LEU PHE ILE SEQRES 6 A 165 SER ILE ASP PRO GLU ARG ASP THR LYS GLU ALA ILE ALA SEQRES 7 A 165 ASN TYR VAL LYS GLU PHE SER PRO LYS LEU VAL GLY LEU SEQRES 8 A 165 THR GLY THR ARG GLU GLU VAL ASP GLN VAL ALA ARG ALA SEQRES 9 A 165 TYR ARG VAL TYR TYR SER PRO GLY PRO LYS ASP GLU ASP SEQRES 10 A 165 GLU ASP TYR ILE VAL ASP HIS THR ILE ILE MSE TYR LEU SEQRES 11 A 165 ILE GLY PRO ASP GLY GLU PHE LEU ASP TYR PHE GLY GLN SEQRES 12 A 165 ASN LYS ARG LYS GLY GLU ILE ALA ALA SER ILE ALA THR SEQRES 13 A 165 HIS MSE ARG PRO TYR ARG LYS LYS SER SEQRES 1 B 165 MSE GLY PRO PHE SER LEU THR THR HIS THR GLY GLU ARG SEQRES 2 B 165 LYS THR ASP LYS ASP TYR LEU GLY GLN TRP LEU LEU ILE SEQRES 3 B 165 TYR PHE GLY PHE THR HIS CYS PRO ASP VAL CYS PRO GLU SEQRES 4 B 165 GLU LEU GLU LYS MSE ILE GLN VAL VAL ASP GLU ILE ASP SEQRES 5 B 165 SER ILE THR THR LEU PRO ASP LEU THR PRO LEU PHE ILE SEQRES 6 B 165 SER ILE ASP PRO GLU ARG ASP THR LYS GLU ALA ILE ALA SEQRES 7 B 165 ASN TYR VAL LYS GLU PHE SER PRO LYS LEU VAL GLY LEU SEQRES 8 B 165 THR GLY THR ARG GLU GLU VAL ASP GLN VAL ALA ARG ALA SEQRES 9 B 165 TYR ARG VAL TYR TYR SER PRO GLY PRO LYS ASP GLU ASP SEQRES 10 B 165 GLU ASP TYR ILE VAL ASP HIS THR ILE ILE MSE TYR LEU SEQRES 11 B 165 ILE GLY PRO ASP GLY GLU PHE LEU ASP TYR PHE GLY GLN SEQRES 12 B 165 ASN LYS ARG LYS GLY GLU ILE ALA ALA SER ILE ALA THR SEQRES 13 B 165 HIS MSE ARG PRO TYR ARG LYS LYS SER SEQRES 1 C 165 MSE GLY PRO PHE SER LEU THR THR HIS THR GLY GLU ARG SEQRES 2 C 165 LYS THR ASP LYS ASP TYR LEU GLY GLN TRP LEU LEU ILE SEQRES 3 C 165 TYR PHE GLY PHE THR HIS CYS PRO ASP VAL CYS PRO GLU SEQRES 4 C 165 GLU LEU GLU LYS MSE ILE GLN VAL VAL ASP GLU ILE ASP SEQRES 5 C 165 SER ILE THR THR LEU PRO ASP LEU THR PRO LEU PHE ILE SEQRES 6 C 165 SER ILE ASP PRO GLU ARG ASP THR LYS GLU ALA ILE ALA SEQRES 7 C 165 ASN TYR VAL LYS GLU PHE SER PRO LYS LEU VAL GLY LEU SEQRES 8 C 165 THR GLY THR ARG GLU GLU VAL ASP GLN VAL ALA ARG ALA SEQRES 9 C 165 TYR ARG VAL TYR TYR SER PRO GLY PRO LYS ASP GLU ASP SEQRES 10 C 165 GLU ASP TYR ILE VAL ASP HIS THR ILE ILE MSE TYR LEU SEQRES 11 C 165 ILE GLY PRO ASP GLY GLU PHE LEU ASP TYR PHE GLY GLN SEQRES 12 C 165 ASN LYS ARG LYS GLY GLU ILE ALA ALA SER ILE ALA THR SEQRES 13 C 165 HIS MSE ARG PRO TYR ARG LYS LYS SER MODRES 1WP0 MSE A 180 MET SELENOMETHIONINE MODRES 1WP0 MSE A 264 MET SELENOMETHIONINE MODRES 1WP0 MSE A 294 MET SELENOMETHIONINE MODRES 1WP0 MSE B 137 MET SELENOMETHIONINE MODRES 1WP0 MSE B 180 MET SELENOMETHIONINE MODRES 1WP0 MSE B 264 MET SELENOMETHIONINE MODRES 1WP0 MSE B 294 MET SELENOMETHIONINE MODRES 1WP0 MSE C 137 MET SELENOMETHIONINE MODRES 1WP0 MSE C 180 MET SELENOMETHIONINE MODRES 1WP0 MSE C 264 MET SELENOMETHIONINE MODRES 1WP0 MSE C 294 MET SELENOMETHIONINE HET MSE A 180 8 HET MSE A 264 8 HET MSE A 294 8 HET MSE B 137 8 HET MSE B 180 8 HET MSE B 264 8 HET MSE B 294 8 HET MSE C 137 8 HET MSE C 180 8 HET MSE C 264 8 HET MSE C 294 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 11(C5 H11 N O2 SE) FORMUL 4 HOH *26(H2 O) HELIX 1 1 LYS A 153 LEU A 156 5 4 HELIX 2 2 ASP A 171 ILE A 190 1 20 HELIX 3 3 THR A 209 GLU A 219 1 11 HELIX 4 4 THR A 230 TYR A 241 1 12 HELIX 5 5 ASP A 251 ASP A 255 5 5 HELIX 6 6 ARG A 282 ARG A 295 1 14 HELIX 7 7 LYS B 153 LEU B 156 5 4 HELIX 8 8 ASP B 171 ILE B 190 1 20 HELIX 9 9 THR B 209 GLU B 219 1 11 HELIX 10 10 THR B 230 TYR B 241 1 12 HELIX 11 11 ARG B 282 ARG B 295 1 14 HELIX 12 12 LYS C 153 LEU C 156 5 4 HELIX 13 13 ASP C 171 ILE C 190 1 20 HELIX 14 14 THR C 209 SER C 221 1 13 HELIX 15 15 THR C 230 TYR C 241 1 12 HELIX 16 16 ARG C 282 ARG C 295 1 14 SHEET 1 A 7 ARG A 149 THR A 151 0 SHEET 2 A 7 SER A 141 THR A 144 -1 N LEU A 142 O LYS A 150 SHEET 3 A 7 VAL A 225 THR A 228 -1 O THR A 228 N THR A 143 SHEET 4 A 7 LEU A 196 SER A 202 1 N PHE A 200 O LEU A 227 SHEET 5 A 7 TRP A 159 GLY A 165 1 N TRP A 159 O THR A 197 SHEET 6 A 7 ILE A 263 ILE A 267 -1 O ILE A 267 N LEU A 160 SHEET 7 A 7 PHE A 273 GLY A 278 -1 O ASP A 275 N LEU A 266 SHEET 1 B 2 TYR A 245 PRO A 247 0 SHEET 2 B 2 VAL A 258 HIS A 260 -1 O ASP A 259 N SER A 246 SHEET 1 C 7 ARG B 149 THR B 151 0 SHEET 2 C 7 SER B 141 THR B 144 -1 N LEU B 142 O LYS B 150 SHEET 3 C 7 VAL B 225 THR B 228 -1 O THR B 228 N THR B 143 SHEET 4 C 7 THR B 197 SER B 202 1 N SER B 202 O LEU B 227 SHEET 5 C 7 LEU B 160 GLY B 165 1 N TYR B 163 O ILE B 201 SHEET 6 C 7 MSE B 264 ILE B 267 -1 O TYR B 265 N ILE B 162 SHEET 7 C 7 PHE B 273 PHE B 277 -1 O LEU B 274 N LEU B 266 SHEET 1 D 2 TYR B 245 PRO B 247 0 SHEET 2 D 2 VAL B 258 HIS B 260 -1 O ASP B 259 N SER B 246 SHEET 1 E 7 ARG C 149 THR C 151 0 SHEET 2 E 7 SER C 141 THR C 144 -1 N LEU C 142 O LYS C 150 SHEET 3 E 7 VAL C 225 THR C 228 -1 O THR C 228 N THR C 143 SHEET 4 E 7 LEU C 196 SER C 202 1 N PHE C 200 O VAL C 225 SHEET 5 E 7 TRP C 159 GLY C 165 1 N TRP C 159 O THR C 197 SHEET 6 E 7 ILE C 263 ILE C 267 -1 O TYR C 265 N ILE C 162 SHEET 7 E 7 PHE C 273 GLY C 278 -1 O ASP C 275 N LEU C 266 SHEET 1 F 2 TYR C 245 PRO C 247 0 SHEET 2 F 2 VAL C 258 HIS C 260 -1 O ASP C 259 N SER C 246 LINK C LYS A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N ILE A 181 1555 1555 1.33 LINK C ILE A 263 N MSE A 264 1555 1555 1.33 LINK C MSE A 264 N TYR A 265 1555 1555 1.33 LINK C HIS A 293 N MSE A 294 1555 1555 1.33 LINK C MSE A 294 N ARG A 295 1555 1555 1.33 LINK C MSE B 137 N GLY B 138 1555 1555 1.33 LINK C LYS B 179 N MSE B 180 1555 1555 1.33 LINK C MSE B 180 N ILE B 181 1555 1555 1.33 LINK C ILE B 263 N MSE B 264 1555 1555 1.33 LINK C MSE B 264 N TYR B 265 1555 1555 1.33 LINK C HIS B 293 N MSE B 294 1555 1555 1.33 LINK C MSE B 294 N ARG B 295 1555 1555 1.33 LINK C MSE C 137 N GLY C 138 1555 1555 1.33 LINK C LYS C 179 N MSE C 180 1555 1555 1.33 LINK C MSE C 180 N ILE C 181 1555 1555 1.33 LINK C ILE C 263 N MSE C 264 1555 1555 1.33 LINK C MSE C 264 N TYR C 265 1555 1555 1.33 LINK C HIS C 293 N MSE C 294 1555 1555 1.33 LINK C MSE C 294 N ARG C 295 1555 1555 1.33 CRYST1 60.210 103.154 103.168 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016609 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009694 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009693 0.00000